Is SCHD a Good ETF to Buy?
With around $65.7 billion in net assets, Schwab’s US Dividend…
Sell
33
PG Quote, Financials, Valuation and Earnings
Last price:
$161.30
Seasonality move
:
-1.57%
Day range:
$160.44 - $163.50
52-week range:
$146.28 - $180.43
Dividend yield:
2.47%
P/E ratio:
27.69x
P/S ratio:
4.73x
P/B ratio:
7.41x
Volume:
8.5M
Avg. volume:
6.8M
1-year change:
8.94%
Market cap:
$378.2B
Revenue:
$84B
EPS (TTM):
$5.80
Analysts' Opinion
-
Consensus RatingProcter & Gamble has received a consensus rating of Buy. The company's average rating is a Buy based on 13 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $181.00, Procter & Gamble has an estimated upside of 12.7% from its current price of $160.60.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $143.00 representing 100% downside risk from its current price of $160.60.
Fair Value
-
According to the consensus of 23 analysts, Procter & Gamble has 12.7% upside to fair value with a price target of $181.00 per share.
PG vs. S&P 500
-
Over the past 5 trading days, Procter & Gamble has underperformed the S&P 500 by -6.75% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Procter & Gamble does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Procter & Gamble revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Procter & Gamble reported revenues of $21.7B.
Earnings Growth
-
Procter & Gamble earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Procter & Gamble reported earnings per share of $1.61.
Enterprise value:
403.3B
EV / Invested capital:
--
Price / LTM sales:
4.73x
EV / EBIT:
21.19x
EV / Revenue:
4.81x
PEG ratio (5yr expected):
14.01x
EV / Free cash flow:
25.44x
Price / Operating cash flow:
25.02x
Enterprise value / EBITDA:
18.37x
Gross Profit (TTM):
$43.1B
Return On Assets:
11.7%
Net Income Margin (TTM):
17.07%
Return On Equity:
28.65%
Return On Invested Capital:
17.04%
Operating Margin:
26.67%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $80.5B | $83.3B | $83.9B | $21.9B | $21.7B | |
| Gross Profit | $37.8B | $40.9B | $43.1B | $11.4B | $11.3B | |
| Operating Income | $17.7B | $19B | $19.9B | $5.8B | $5.8B | |
| EBITDA | $21.2B | $22.8B | $22B | $6.7B | $6.1B | |
| Diluted EPS | $5.77 | $6.16 | $5.80 | $1.83 | $1.61 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $26B | $24.3B | $22.5B | $24.9B | $27.4B | |
| Total Assets | $119.9B | $119.7B | $116.3B | $122.5B | $126.5B | |
| Current Liabilities | $30B | $36.6B | $36.6B | $37.2B | $36.4B | |
| Total Liabilities | $71.3B | $73.3B | $71.9B | $74.5B | $74.3B | |
| Total Equity | $48.6B | $46.4B | $44.3B | $48B | $52.1B | |
| Total Debt | $31.7B | $32.5B | $33B | $35.9B | $36.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $16.2B | $17.7B | $19.2B | $4.9B | $4.3B | |
| Cash From Investing | -$4.3B | -$3.9B | -$3.4B | -$1.2B | -$1.1B | |
| Cash From Financing | -$15B | -$10.7B | -$13.5B | -$2B | -$634M | |
| Free Cash Flow | $13.2B | $14.6B | $15.9B | $4B | $3.3B | |
PG
Sector
Market Cap
$378.2B
$327.2M
Price % of 52-Week High
89.01%
72.58%
Dividend Yield
2.47%
0%
Shareholder Yield
3.51%
2.68%
1-Year Price Total Return
8.94%
-13.49%
Beta (5-Year)
0.454
0.503
Dividend yield:
2.47%
Annualized payout:
$3.83
Payout ratio:
66.12%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$166.89
200-day SMA
Sell
Level
$167.57
Bollinger Bands (100)
Sell
Level
166.93 - 174.65
Chaikin Money Flow
Buy
Level
1.8B
20-day SMA
Sell
Level
$169.02
Relative Strength Index (RSI14)
Sell
Level
25.70
ADX Line
Sell
Level
29.8
Williams %R
Buy
Level
-98.7034
50-day SMA
Sell
Level
$169.85
MACD (12, 26)
Sell
Level
-1.96
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
1.2B
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (5.8012)
Buy
CA Score
(Annual)
Level (0.0727)
Buy
Beneish M-Score
(Annual)
Level (-2.6135)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-1.4079)
Buy
Piotroski F Score
(Annual)
Level (8)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
Stock Forecast FAQ
In the current month, PG has received 13 Buy ratings 10 Hold ratings, and 0 Sell ratings. The PG average analyst price target in the past 3 months is $181.00.
-
Where Will Procter & Gamble Stock Be In 1 Year?
According to analysts, the consensus estimate is that Procter & Gamble share price will rise to $181.00 per share over the next 12 months.
-
What Do Analysts Say About Procter & Gamble?
Analysts are divided on their view about Procter & Gamble share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Procter & Gamble is a Sell and believe this share price will drop from its current level to $143.00.
-
What Is Procter & Gamble's Price Target?
The price target for Procter & Gamble over the next 1-year time period is forecast to be $181.00 according to 23 Wall Street analysts, 13 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is PG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Procter & Gamble is a Buy. 13 of 23 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of PG?
You can purchase shares of Procter & Gamble via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Procter & Gamble shares.
-
What Is The Procter & Gamble Share Price Today?
Procter & Gamble was last trading at $161.30 per share. This represents the most recent stock quote for Procter & Gamble. Yesterday, Procter & Gamble closed at $160.60 per share.
-
How To Buy Procter & Gamble Stock Online?
In order to purchase Procter & Gamble stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is NAIL a Good ETF to Buy?
If you’re thinking about buying the NAIL ETF, this article…
3 High Dividend Dow Jones Stocks
Thanks to surging stock prices over the past two years,…
Stock Ideas
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 125x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
50
NARI alert for Jan 7
Inari Medical [NARI] is up 22.25% over the past day.
Buy
70
PDEX alert for Jan 7
Pro-Dex [PDEX] is down 10.89% over the past day.
Buy
52
ALCO alert for Jan 7
Alico [ALCO] is down 3.89% over the past day.
